Standards Comparison

    J-SOX

    Mandatory
    2008

    Japanese regulation for ICFR in listed companies

    VS

    ISO 13485

    Mandatory
    2016

    International standard for medical device quality management systems

    Quick Verdict

    J-SOX mandates ICFR for Japanese listed firms to ensure financial reporting reliability via management assessment and audits. ISO 13485 provides voluntary QMS certification for medical device makers to prove safety and regulatory compliance globally. Companies adopt J-SOX for market listing; ISO 13485 for access and trust.

    Financial Reporting

    J-SOX

    Financial Instruments and Exchange Act (FIEA)

    Cost
    €€€€
    Complexity
    High
    Implementation Time
    12-18 months

    Key Features

    • Mandatory ICFR for 3,800 listed companies and subsidiaries
    • Principles-based flexible control design and scoping
    • Explicit central focus on IT governance controls
    • Management assessment with external auditor attestation
    • COSO-aligned framework plus Response to IT
    Quality Management

    ISO 13485

    ISO 13485:2016 Medical devices Quality management systems

    Cost
    €€€€
    Complexity
    High
    Implementation Time
    12-18 months

    Key Features

    • Risk-based QMS for medical device lifecycle
    • Documented procedures and medical device files
    • Process validation and traceability requirements
    • Post-market surveillance and complaint handling
    • Supplier controls and regulatory integration

    Detailed Analysis

    A comprehensive look at the specific requirements, scope, and impact of each standard.

    J-SOX Details

    What It Is

    J-SOX, or Japan's internal control over financial reporting under the Financial Instruments and Exchange Act (FIEA) promulgated in 2006, is a regulatory framework mandating ICFR assessment for listed companies effective April 2008. It employs a principles-based, risk-based approach focusing on reliable financial reporting, asset preservation, and Securities Report disclosures.

    Key Components

    • Five COSO components plus explicit Response to Information Technology.
    • Entity-level, process-level, and IT general controls (access, change management, operations).
    • Risk assessment, key control identification, documentation, testing, and monitoring.
    • Management evaluation with external auditor attestation on report reliability.

    Why Organizations Use It

    • Legal mandate for ~3,800 listed firms and subsidiaries avoids FSA penalties, fines, delisting.
    • Enhances reporting reliability, investor trust, reduces restatement risks.
    • Drives operational efficiency, IT governance maturity, strategic governance signaling.

    Implementation Overview

    • Phased: governance, scoping, design, testing, reporting, continuous monitoring.
    • Targets listed/multinational companies in Japan; requires documentation, evidence, remediation.
    • Auditor review; no separate certification but filed internal control reports.

    ISO 13485 Details

    What It Is

    ISO 13485:2016 is the international standard titled Medical devices — Quality management systems — Requirements for regulatory purposes. It is a certifiable framework for organizations in the medical device lifecycle, emphasizing risk-based controls to ensure devices meet customer and regulatory requirements consistently.

    Key Components

    • Organized into Clauses 4–8: QMS/documentation, management responsibility, resources, product realization, measurement/improvement.
    • Requires documented procedures, medical device files, validation, traceability, and post-market surveillance.
    • Built on process approach with ISO 9001 compatibility but enhanced for regulatory needs like risk management (ISO 14971).
    • Certification via accredited bodies with stage audits and surveillance.

    Why Organizations Use It

    • Enables market access (EU MDR, FDA QMSR alignment by 2026).
    • Mitigates risks of recalls, liabilities via robust controls.
    • Builds stakeholder trust, supplier credibility, operational efficiency.

    Implementation Overview

    • Phased: gap analysis, process design, validation, audits.
    • Applies to manufacturers, suppliers globally; scales by size.
    • Involves eQMS, training, CAPA; certification every 3 years. (178 words)

    Key Differences

    Scope

    J-SOX
    ICFR for financial reporting reliability
    ISO 13485
    QMS for medical device lifecycle safety

    Industry

    J-SOX
    Japanese listed companies and subsidiaries
    ISO 13485
    Global medical device manufacturers/suppliers

    Nature

    J-SOX
    Mandatory FIEA securities regulation
    ISO 13485
    Voluntary certification standard

    Testing

    J-SOX
    Annual management assessment, auditor review
    ISO 13485
    Internal audits, certification body audits

    Penalties

    J-SOX
    FSA fines, reputational damage
    ISO 13485
    Loss of certification, market access denial

    Frequently Asked Questions

    Common questions about J-SOX and ISO 13485

    J-SOX FAQ

    ISO 13485 FAQ

    You Might also be Interested in These Articles...

    Run Maturity Assessments with GRADUM

    Transform your compliance journey with our AI-powered assessment platform

    Assess your organization's maturity across multiple standards and regulations including ISO 27001, DORA, NIS2, NIST, GDPR, and hundreds more. Get actionable insights and track your progress with collaborative, AI-powered evaluations.

    100+ Standards & Regulations
    AI-Powered Insights
    Collaborative Assessments
    Actionable Recommendations

    Check out these other Gradum.io Standards Comparison Pages